belantamab mafodotin,carfilzomib
gsk,amgen
blenrep combo with kyprolis-dex in heavily pretreated patients; manageable safety profile, some deep responses in a 10 patient cohort. #ims2022 
Multiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patient’s lives, and lead to a cure.